News and Trends 10 Jul 2015
First-in-human successful Phase I for an Alzheimer’s vaccine
AXON Neuroscience has completed a pioneer Phase I that offers new hope for millions of patients with Alzheimer’s disease. This…
Lourdes Riquelme
About
Spanish Biotechnologist with a MS in Genetics from Universidad Autonoma of Barcelona. My interests go from science to fashion and anything in between.Articles by Lourdes Riquelme
News and Trends 9 Jul 2015
Vision specialist Gensight eyes a €90M IPO on NASDAQ
French Gensight intends to raise one of the biggest European IPOs on the American stock market. The gene-therapy specialist will…
News and Trends 9 Jul 2015
Oasmia anticipates an Oncology market growth and seeks €23M on NASDAQ
Human and veterinary oncologist Oasmia files for a €23M IPO on the American NASDAQ. The Swedish company, anticipating an increase…
News and Trends 8 Jul 2015
Genmab and Novartis look for the European approval of their leukemia candidate
Genmab is seeking the European authorization for Arzerra, a treatment co-developed with Novartis. The submission is based on the candidate’s…
ADVERTISEMENT
News and Trends 7 Jul 2015
DIY-Morphine is around the corner with recent Discoveries in Poppies
Bioproduction of future painkillers such as morphine could become a reality. Researchers from the University of York and GlaxoSmithKline Australia made crucial…
News and Trends 6 Jul 2015
Kiadis launches its Cell-based Immunotherapies on European stock markets
Kiadis Pharma has launched an IPO on Euronext Amsterdam and Euronext Brussels with the aim of raising €32.7M. The company…
News and Trends 5 Jul 2015
CEVEC and Biotest to ease hemophilia patients’ lifes
A German collaboration seeks to treat the symptoms of hemophilia in patients suffering from the later. CEVEC and Biotest will…
News and Trends 3 Jul 2015
Nobel Prize’s company start gathering robust clinical data in two phases II
Cell Therapy’s Tendoncel, a topical gel for the treatment of severe tendon injuries, has successfully completed its phase II. The…
News and Trends 2 Jul 2015
Nanobiotix got the all-clear for its new Phase I/II clinical trial
The French National Agency for Medicines and Health Products gave Nanobiotix the green light to start a Phase I/II trial…
News and Trends 2 Jul 2015
Roche and Evotec knocked down by their Alzheimer candidate
The progressive aging of the population in developed countries is turning Alzheimer into one of the biggest medical challenges of…
ADVERTISEMENT
News and Trends 1 Jul 2015
Is Adocia & Eli Lilly’s treatment the new diabetes blockbuster?
Adocia and Eli Lilly completed an impressive Phase Ib clinical trial evaluating BioChaperone Lispro, a treatment designed to accelerate insulin…
News and Trends 1 Jul 2015
Two of Alexion’s rare-disease drugs get the thumbs up from the EU
The European Medicines Agency (EMA) is about to approve a couple of rare diseases drugs developed by Alexion. The two…
News and Trends 1 Jul 2015
Green light for one of the largest clinical trials in Immunotherapy
In a period, where uncountable big pharmas and biotechs are struggling to get the largest piece of the immunotherapy cake, an unexpected…
News and Trends 29 Jun 2015
Actelion & the Max Planck Society created the new leader in Synthetic Carbohydrate Vaccines
Actelion has created a new start-up in the field of synthetic carbohydrate vaccines, together with the Max Planck Society. Actelion…
News and Trends 28 Jun 2015
Google and big names helped Oxford Sciences Innovation to raise €457M
Oxford Sciences Innovation has completed the second close of its fundraising, raising an additional €157.3M (£110M) and bringing the total…
News and Trends 25 Jun 2015
AstraZeneca’s senior managers are abandoning ship
In just a couple of weeks, AstraZeneca has seen two of its chiefs leave their position to run two smaller biotechs.…
ADVERTISEMENT
News and Trends 25 Jun 2015
BioNTech and Siemens to build a new Production plant for Personalized Cancer Vaccines
Personalized medicine is the next thing and immunotherapy expert BioNTech is determined to build its place in this competitive field.…
News and Trends 25 Jun 2015
A treatment for Spinal Muscular Atrophy received Orphan Drug designation
The European Medicines Agency has granted Orphan Drug designation to AveXis’ gene transfer candidate. The therapy is currently in clinical…
News and Trends 24 Jun 2015
AYOXXA and Grünenthal collaborate on inflammation markers
AYOXXA Biosystems and Grünenthal have completed their first research collaboration to validate detection limits for a biomarker based on AYOXXA’s…
News and Trends 23 Jun 2015
DBV Technologies to cure Peanut allergy
DBV Technologies plans the initiation of its phase III clinical trial for Viaskin Peanut, after a satisfactory conclusion of the…